{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:44:18Z","timestamp":1792842258359,"version":"4.5.0"},"reference-count":234,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.semnephrol.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T11:50:47Z","timestamp":1541505047000},"page":"542-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Joseph","family":"Lunyera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2018.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0002","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0003","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2016090944","article-title":"The pas de trois of vitamin D, FGF23, and PTH","volume":"28","author":"Naveh-Many","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0005","article-title":"Conditional deletion of Fgfr1 in the proximal and distal tubule identifies distinct roles in phosphate and calcium transport","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0006","first-page":"229","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0008","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0010","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jbmr.3195","article-title":"Klotho lacks an FGF23-independent role in mineral homeostasis","volume":"32","author":"Andrukhova","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0011","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0012","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1681\/ASN.2014101030","article-title":"Renal production, uptake, and handling of circulating alphaklotho","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000438999","article-title":"Race, mineral homeostasis and mortality in patients with end-stage renal disease on dialysis","volume":"42","author":"Scialla","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0014","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0016","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0017","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0018","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjhf\/hfq106","article-title":"Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community","volume":"12","author":"Dhingra","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0019","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0020","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0021","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3945\/ajcn.114.085167","article-title":"Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study","volume":"100","author":"Lutsey","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0023","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0024","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor 23 and cardiovascular events in chronic kidney disease","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamacardio.2016.1445","article-title":"Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the Chronic Renal Insufficiency Cohort study","volume":"1","author":"Mehta","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0027","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","article-title":"Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)","volume":"130","author":"Mathew","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1681\/ASN.2014101009","article-title":"Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study","volume":"27","author":"Chonchol","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000936","article-title":"Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study","volume":"3","author":"Lutsey","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0032","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/STROKEAHA.114.007489","article-title":"Fibroblast growth factor 23 and risk of incident stroke in community-living adults","volume":"46","author":"Panwar","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0033","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jc.2016-2215","article-title":"Fibroblast growth factor 23 and cause-specific mortality in the general population: the Northern Manhattan Study","volume":"101","author":"Souma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0034","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MNH.0000000000000123","article-title":"Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease","volume":"24","author":"Scialla","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0035","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0036","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and chronic kidney disease progression in African Americans","volume":"24","author":"Scialla","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0037","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2016040401","article-title":"Fibroblast growth factor 23 and the risk of infection-related hospitalization in older adults","volume":"28","author":"Nowak","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0038","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1210\/jc.2017-01868","article-title":"Biomarkers of mineral and bone metabolism and 20-year risk of hospitalization with infection: the Atherosclerosis Risk in Communities Study","volume":"102","author":"Ishigami","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0039","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1210\/jc.2017-00104","article-title":"Circulating klotho associates with cardiovascular morbidity and mortality during hemodialysis","volume":"102","author":"Marcais","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.2012.288","article-title":"Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease","volume":"83","author":"Seiler","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0041","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.08.017","article-title":"Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"242","author":"Brandenburg","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0042","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0043","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4","volume":"9","author":"Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0044","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/j.ajkd.2013.01.024","article-title":"Circulating alpha-klotho levels in CKD and relationship to progression","volume":"61","author":"Kim","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2018.08.001_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100688","article-title":"Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients","volume":"9","author":"Nowak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0047","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0048","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0049","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","article-title":"Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality","volume":"168","author":"Dobnig","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-156-9-201205010-00004","article-title":"Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study","volume":"156","author":"de Boer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0051","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2012.17304","article-title":"Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes","volume":"308","author":"Levin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0052","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2013.7228","article-title":"Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events","volume":"310","author":"Robinson-Cohen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0053","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0054","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2017.05.031","article-title":"Vitamin D and cardiovascular disease: controversy unresolved","volume":"70","author":"Al Mheid","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0056","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0057","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0058","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0059","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3945\/an.115.008631","article-title":"Essential nutrient interactions: does low or suboptimal magnesium status interact with vitamin D and\/or calcium status","volume":"7","author":"Rosanoff","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0061","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.ajkd.2015.05.024","article-title":"Hypomagnesemia and mortality in incident hemodialysis patients","volume":"66","author":"Li","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0062","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.atherosclerosis.2011.05.038","article-title":"Low serum magnesium concentrations predict cardiovascular and all-cause mortality","volume":"219","author":"Reffelmann","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0063","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1681\/ASN.2017060640","article-title":"Dialysate potassium, dialysate magnesium, and hemodialysis risk","volume":"28","author":"Pun","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0064","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.HYP.38.3.434","article-title":"Arterial wave reflections and survival in end-stage renal failure","volume":"38","author":"London","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0066","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0067","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/sdi.12616","article-title":"Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients","volume":"31","author":"Gungor","year":"2017","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0068","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11914-015-0293-9","article-title":"Pathophysiology of vascular calcification","volume":"13","author":"Chen","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0069","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2009.83","article-title":"Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin","volume":"75","author":"El-Abbadi","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0071","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0072","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ki.2012.322","article-title":"Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet","volume":"82","author":"Lau","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0073","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice","volume":"18","author":"Stubbs","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0074","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2012.300","article-title":"High phosphate directly affects endothelial function by downregulating annexin II","volume":"83","author":"Di Marco","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function","volume":"20","author":"Shuto","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0076","doi-asserted-by":"crossref","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0077","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jcmm.12996","article-title":"The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells","volume":"21","author":"Maltese","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0078","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial","volume":"42","author":"Lundwall","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0079","doi-asserted-by":"crossref","first-page":"e91363","DOI":"10.1371\/journal.pone.0091363","article-title":"Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients","volume":"9","author":"Chitalia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0081","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0082","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0083","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0084","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016795","article-title":"The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale","volume":"7","author":"Bressendorff","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0086","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ekir.2016.12.008","article-title":"Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity-a prospective randomized double-blinded placebo-controlled clinical trial","volume":"2","author":"Bressendorff","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0087","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40697-015-0053-x","article-title":"Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease","volume":"2","author":"Holden","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0089","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1161\/CIR.0000000000000395","article-title":"The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation","volume":"133","author":"Sacco","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0091","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006802","article-title":"Effect of monthly, high-dose, long-term vitamin D supplementation on central blood pressure parameters: a randomized controlled trial substudy","volume":"6","author":"Sluyter","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0092","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1152\/ajpregu.00124.2016","article-title":"High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats","volume":"311","author":"Mizuno","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0093","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/HJH.0000000000000261","article-title":"High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin","volume":"32","author":"Bozic","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0094","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/HYPERTENSIONAHA.107.103747","article-title":"Dietary phosphorus and blood pressure: international study of macro- and micro-nutrients and blood pressure","volume":"51","author":"Elliott","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0096","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.109.143461","article-title":"Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis","volume":"55","author":"Alonso","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0097","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1161\/CIRCULATIONAHA.112.114058","article-title":"A nutrient-wide association study on blood pressure","volume":"126","author":"Tzoulaki","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0098","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0099","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1159\/000452601","article-title":"High dialysate calcium concentration may cause more sympathetic stimulus during hemodialysis","volume":"41","author":"Jimenez","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1751-7176.2011.00503.x","article-title":"Serum calcium levels and hypertension among U.S. adults","volume":"13","author":"Sabanayagam","year":"2011","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0101","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.116.07664","article-title":"Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials","volume":"68","author":"Zhang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0102","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HJH.0000000000000936","article-title":"Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study","volume":"34","author":"Fyfe-Johnson","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0103","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"de Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0104","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jchf.2015.05.012","article-title":"Association of fibroblast growth factor-23 levels and angiotensin-converting enzyme inhibition in chronic systolic heart failure","volume":"3","author":"Wohlfahrt","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ndt\/gfw105","article-title":"Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis","volume":"32","author":"de Jong","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0106","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","article-title":"Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade","volume":"65","author":"Humalda","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0108","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000441684","article-title":"Mineral metabolites, angiotensin II inhibition and outcomes in advanced chronic kidney disease","volume":"42","author":"Jovanovich","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0109","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","article-title":"Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease","volume":"63","author":"Udell","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ki.2012.303","article-title":"Dietary phosphorus is associated with greater left ventricular mass","volume":"83","author":"Yamamoto","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00467-017-3766-5","article-title":"The FGF23-klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study","volume":"33","author":"Tranaeus Lindblad","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156860","article-title":"Association between FGF23, alpha-klotho, and cardiac abnormalities among patients with various chronic kidney disease stages","volume":"11","author":"Tanaka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0113","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0114","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.ajkd.2010.03.030","article-title":"Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the heart and soul study","volume":"56","author":"Saab","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0116","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0117","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Ped Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2017040412","article-title":"Cardiovascular effects of renal distal tubule deletion of the FGF receptor 1 gene","volume":"29","author":"Han","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0119","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0120","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0121","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MNH.0000000000000231","article-title":"The role of fibroblast growth factor 23 and klotho in uremic cardiomyopathy","volume":"25","author":"Grabner","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0122","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0123","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0124","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2014060543","article-title":"Klotho protects against indoxyl sulphate-induced myocardial hypertrophy","volume":"26","author":"Yang","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0125","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD","volume":"26","author":"Isakova","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0126","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2215\/CJN.10000912","article-title":"Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients","volume":"8","author":"Pun","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0127","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1210\/jc.2016-3563","article-title":"Fibroblast growth factor 23, mineral metabolism, and adiposity in normal kidney function","volume":"102","author":"Zaheer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","article-title":"Up-regulation of FGF23 release by aldosterone","volume":"470","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0129","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0131","doi-asserted-by":"crossref","first-page":"11298","DOI":"10.1038\/s41598-017-10140-4","article-title":"Genetic ablation of Fgf23 or klotho does not modulate experimental heart hypertrophy induced by pressure overload","volume":"7","author":"Slavic","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0132","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jbmr.2527","article-title":"Experimental myocardial infarction upregulates circulating fibroblast growth factor-23","volume":"30","author":"Andrukhova","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0133","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0134","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0135","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0136","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0137","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0138","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2016.09.006","article-title":"Assessing vitamin D status in African Americans and the influence of vitamin D on skeletal health parameters","volume":"46","author":"Shieh","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0139","unstructured":"National Center for Biotechnology Information. Database of genotypes and phenotypes. [cited 2017 Nov 28]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gap."},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0140","article-title":"Genome-wide association study of serum minerals levels in children of different ethnic background","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003796","article-title":"Meta-analysis of genome-wide association studies identifies six new loci for serum calcium concentrations","volume":"9","author":"O'Seaghdha","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0142","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/jhg.2015.46","article-title":"Association of common variants in the calcium-sensing receptor gene with serum calcium levels in East Asians","volume":"60","author":"Vinayagamoorthy","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(10)60588-0","article-title":"Common genetic determinants of vitamin D insufficiency: a genome-wide association study","volume":"376","author":"Wang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0144","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.2016010069","article-title":"Genetic variants associated with circulating parathyroid hormone","volume":"28","author":"Robinson-Cohen","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0145","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/hmg\/ddq155","article-title":"Genome-wide association study of circulating vitamin D levels","volume":"19","author":"Ahn","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0146","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2009111104","article-title":"Common genetic variants associate with serum phosphorus concentration","volume":"21","author":"Kestenbaum","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0147","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3945\/ajcn.113.080309","article-title":"Genome-wide association study of circulating vitamin D-binding protein","volume":"99","author":"Moy","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001045","article-title":"Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels","volume":"6","author":"Meyer","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0149","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12863-015-0219-7","article-title":"Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"16","author":"Tin","year":"2015","journal-title":"BMC Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2013.01.103","article-title":"Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort)","volume":"62","author":"Ferguson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2015.08.034","article-title":"Genome-wide association study on progression of carotid artery intima media thickness over 10 years in a Chinese cohort","volume":"243","author":"Xie","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0152","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0153","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00439-014-1439-z","article-title":"Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans","volume":"133","author":"Ellis","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0154","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/hr.2014.56","article-title":"Genetic risk assessment for cardiovascular disease with seven genes associated with plasma C-reactive protein concentrations in Asian populations","volume":"37","author":"Hong","year":"2014","journal-title":"Hypertens Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajhg.2008.03.015","article-title":"Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study","volume":"82","author":"Ridker","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0156","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001398","article-title":"Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension","volume":"3","author":"Fontana","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0157","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/jhh.2009.86","article-title":"Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and\/or hypertension in two Korean cohorts","volume":"24","author":"Hong","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0158","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/jhg.2010.31","article-title":"Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population","volume":"55","author":"Hong","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0159","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ajhg.2011.10.013","article-title":"Blood pressure loci identified with a gene-centric array","volume":"89","author":"Johnson","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/HYPERTENSIONAHA.113.01148","article-title":"Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci","volume":"62","author":"Kelly","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0161","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","article-title":"Genome-wide association study of blood pressure and hypertension","volume":"41","author":"Levy","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0162","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/ddu478","article-title":"Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension","volume":"24","author":"Lu","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0163","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/jhh.2011.50","article-title":"The combined impact of 12 common variants on hypertension in Japanese men, considering GWAS results","volume":"26","author":"Miyaki","year":"2012","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0164","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.110.153429","article-title":"Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project","volume":"56","author":"Tabara","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0165","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/CIRCULATIONAHA.109.904664","article-title":"Blood pressure and hypertension are associated with 7 loci in the Japanese population","volume":"121","author":"Takeuchi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0166","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/HYPERTENSIONAHA.108.112664","article-title":"Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population","volume":"51","author":"Tobin","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0167","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1007\/s11033-014-3434-9","article-title":"Genetic predisposition to calcific aortic stenosis and mitral annular calcification","volume":"41","author":"Kutikhin","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0168","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1038\/srep19079","article-title":"Association between the DOCK7, PCSK9 and GALNT2 gene polymorphisms and serum lipid levels","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0169","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCGENETICS.111.962365","article-title":"Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study","volume":"6","author":"Fox","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0171","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.2013.276305","article-title":"Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes","volume":"310","author":"Qi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0172","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","article-title":"Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium","volume":"3","author":"Smith","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0173","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11886-015-0584-x","article-title":"Genetic risk factors and Mendelian randomization in cardiovascular disease","volume":"17","author":"Swerdlow","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0174","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI84840","article-title":"Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function","volume":"127","author":"Wild","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0175","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1210\/jc.2006-0071","article-title":"Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality","volume":"92","author":"Marz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119459","article-title":"Association studies of calcium-sensing receptor (CaSR) polymorphisms with serum concentrations of glucose and phosphate, and vascular calcification in renal transplant recipients","volume":"10","author":"Babinsky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0177","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ije\/dyv078","article-title":"No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study","volume":"44","author":"Brondum-Jacobsen","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0178","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.numecd.2017.06.002","article-title":"Impact of polymorphism rs7041 and rs4588 of vitamin D binding protein on the extent of coronary artery disease","volume":"27","author":"Daffara","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0179","doi-asserted-by":"crossref","first-page":"e37295","DOI":"10.1371\/journal.pone.0037295","article-title":"Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromso Study","volume":"7","author":"Jorde","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0180","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1373\/clinchem.2012.193185","article-title":"Vitamin D and mortality: a Mendelian randomization study","volume":"59","author":"Trummer","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0181","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/ajh\/hpu049","article-title":"Common genetic variations in the vitamin D pathway in relation to blood pressure","volume":"27","author":"Wang","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0182","doi-asserted-by":"crossref","first-page":"g6330","DOI":"10.1136\/bmj.g6330","article-title":"Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts","volume":"349","author":"Afzal","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0183","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/1354750X.2014.939226","article-title":"Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence","volume":"19","author":"Hassanein","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0184","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/ATVBAHA.110.211805","article-title":"Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification","volume":"30","author":"Shen","year":"2010","journal-title":"Arterioslerol Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0185","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0186","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2217\/pgs.09.101","article-title":"Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension","volume":"10","author":"Wilke","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0187","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1359\/jbmr.090516","article-title":"Klotho variants and chronic hemodialysis mortality","volume":"24","author":"Friedman","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0188","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jcmm.12710","article-title":"Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease","volume":"20","author":"Donate-Correa","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0189","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00467-017-3877-z","article-title":"Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis","volume":"33","author":"Elghoroury","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0190","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1093\/ndt\/gfr188","article-title":"Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort","volume":"26","author":"Tangri","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0191","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2014.11.013","article-title":"Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (Atherosclerosis Risk in Communities) study","volume":"3","author":"Lutsey","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0192","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/ene.12731","article-title":"Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"22","author":"Schneider","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0193","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vph.2017.04.001","article-title":"Vitamin D binding protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor","volume":"93-95","author":"Verdoia","year":"2017","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0194","doi-asserted-by":"crossref","first-page":"E2133","DOI":"10.1210\/jc.2014-1389","article-title":"Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial","volume":"99","author":"Barry","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0195","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3945\/ajcn.113.066605","article-title":"25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm","volume":"100","author":"Durazo-Arvizu","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0196","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwq005","article-title":"Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study","volume":"171","author":"Jorde","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0197","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00223-017-0339-3","article-title":"Prebiotics, bone and mineral metabolism","volume":"102","author":"Whisner","year":"2017","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2018.08.001_bib0198","doi-asserted-by":"crossref","first-page":"838S","DOI":"10.1093\/jn\/137.3.838S","article-title":"Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure","volume":"137","author":"Scholz-Ahrens","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0199","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1210\/jc.2016-1658","article-title":"Use of estrogen-containing contraception is associated with increased concentrations of 25-hydroxy vitamin D","volume":"101","author":"Harmon","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/07315724.1998.10718760","article-title":"The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels","volume":"17","author":"Harris","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0201","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.05440517","article-title":"The effect of extended release niacin on markers of mineral metabolism in CKD","volume":"13","author":"Malhotra","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0202","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0203","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000353569","article-title":"Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease","volume":"38","author":"Seifert","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0205","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2215\/CJN.03030317","article-title":"Randomized clinical trial of sevelamer carbonate on serum klotho and fibroblast growth factor 23 in CKD","volume":"12","author":"Liabeuf","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0206","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2369-15-71","article-title":"Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial","volume":"15","author":"Urena-Torres","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0207","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0208","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0209","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0211","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0213","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0214","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2215\/CJN.04380417","article-title":"Getting out of the phosphate bind: trials to guide treatment targets","volume":"12","author":"Olivo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ki.2014.383","article-title":"Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial","volume":"87","author":"Kalil","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0216","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2015-2279","article-title":"Impact of phosphorus-based food additives on bone and mineral metabolism","volume":"100","author":"Gutierrez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0217","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0219","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ejcn.2017.59","article-title":"Effects of vitamin D or its analogues on the mortality of patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfx059","article-title":"High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD stages 3-4: results of a 12-week double-blind, randomized, controlled study","volume":"33","author":"Westerberg","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0221","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0222","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cct.2015.12.022","article-title":"Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)","volume":"47","author":"Bassuk","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0223","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0224","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2215\/CJN.03270314","article-title":"Effect of cinacalcet and vitamin D analogs on fibroblast growth factor-23 during the treatment of secondary hyperparathyroidism","volume":"10","author":"Sprague","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0226","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.CIR.64.4.669","article-title":"The randomized clinical trial: bias in analysis","volume":"64","author":"May","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0227","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0228","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0229","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.11141016","article-title":"Calcium-sensing receptor genotype and response to cinacalcet in patients undergoing hemodialysis","volume":"12","author":"Moe","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0230","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3945\/ajcn.114.085498","article-title":"Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study","volume":"100","author":"Ix","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0231","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/aje\/kwx297","article-title":"Measurement of vitamin D for epidemiologic and clinical research: shining light on a complex decision","volume":"187","author":"Jukic","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0232","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1515\/cclm-2013-0208","article-title":"Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs","volume":"51","author":"Smith","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0233","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","article-title":"Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions","volume":"52","author":"Cantor","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.semnephrol.2018.08.001_bib0234","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/jbmr.2252","article-title":"Standardizing vitamin D assays: the way forward","volume":"29","author":"Binkley","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"Supplement C","key":"10.1016\/j.semnephrol.2018.08.001_bib0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2016.10.016","article-title":"Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - a view from the IFCC Working Group for PTH","volume":"467","author":"Sturgeon","year":"2017","journal-title":"Clin Chim Acta"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518301268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518301268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:02:12Z","timestamp":1775260932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929518301268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":234,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0270929518301268"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.08.001","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}